• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: RCH4 synthesized dimer peptide that links a lipid raft receptor to the extracellular matrix
Date Designated: 05/19/2021
Orphan Designation: Treatment of Amyotrophic Lateral Sclerosis (ALS) also known as Motor Neurone Disease (MND)
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
R. Curran (a.k.a. The RC Charity)
56, Amanda Close
Chigwell, Essex IG7 5JG
United Kingdom

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.